The science
Azelaic acid has a solid evidence base, and almost all of it is at concentrations this serum does not approach. A 2023 systematic review in the Journal of Cosmetic Dermatology assessed azelaic acid across acne, rosacea, melasma and photoaging and found consistent benefit in the 15 to 20 percent range, with a 2020 abridged Cochrane review in the Journal of Evidence-Based Medicine rating 20 percent azelaic acid as probably comparable to benzoyl peroxide and tretinoin for acne, at moderate certainty. The mechanisms, inhibition of Cutibacterium acnes, normalisation of keratinisation, anti-inflammatory action and tyrosinase inhibition, are dose-dependent, and a formula listing the acid thirty-first is not in the range where any of them has been measured.
The ingredient that carries the activity here is potassium azeloyl diglycinate, a glycine conjugate of azelaic acid designed for water-based cosmetics. The published work on it is thinner and mostly in vitro: a 2017 Italian dermatology journal study reported that azeloglycine, alone and with nicotinamide, down-regulated pro-inflammatory mediators in cultured keratinocytes, and 2024 and 2025 formulation studies in Polish and Swiss journals characterised its stability and antimicrobial contribution in anti-acne hydrogels alongside tetracycline. That supports a plausible calming, sebum-regulating effect at cosmetic doses without establishing an effect size on acne in people, which matches the gradual, modest changes users describe.
The pre- and postbiotic ingredients have laboratory and small-study data on barrier markers and inflammation and no acne trials; they function reliably as humectants. The natural-moisturising-factor cluster, sodium PCA, lactate, PCA, amino acids and hydrolysed hyaluronate, replicates components of the skin's own water-binding system and explains the hydrated, calmer feel that arrives within days, before any acid could act. The brand's cited consumer perception study of 21 participants reports what people said they saw, without a control group or objective measurement, and cannot be treated as efficacy evidence.
References 4 ShowHide
- A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging — Journal of Cosmetic Dermatology (2023)
- Evidence-based topical treatments (azelaic acid, salicylic acid, nicotinamide, sulfur, zinc, and fruit acid) for acne: an abridged version of a Cochrane systematic review — Journal of Evidence-Based Medicine (2020)
- Azeloglycine and nicotinamide down-regulate pro-inflammatory mediators in vitro — Giornale Italiano di Dermatologia e Venereologia (2017)
- Synergy of Tetracyclines and Potassium Azeloyl Diglycinate (Azeloglycine) in Hydrogels: Evaluation of Stability, Antimicrobial Activity, and Physicochemical Properties — International Journal of Molecular Sciences (2025)